GA²CI had a strong and impactful presence at the EAACI Congress 2026 in Istanbul, contributing through scientific presentations, posters, educational activities, and international collaborations.

​

A major highlight was the successful GA²CI–EAACI Sister Society Symposium, which showcased advances in clinical immunology, biologic therapies, and diagnostic challenges in the Arabian Peninsula. 

​

GA²CI members presented research across a broad range of topics, including severe asthma, atopic dermatitis, biologic therapies, primary immunodeficiency, precision medicine, and real-world evidence. Poster and oral presentations demonstrated the growing scientific productivity and research excellence of the region.

​

The GA²CI Junior Assembly was actively engaged through abstract presentations, poster judging, and networking activities, reflecting the organization's commitment to nurturing future leaders in allergy and clinical immunology.

Overall, GA²CI's participation at EAACI 2026 strengthened its international profile, fostered new collaborations, and highlighted the important contributions of its members to advancing allergy, asthma, and clinical immunology research and patient care.

​

GA2CI Leadership sincerely thanks all speakers, presenters, judges, faculty members, and attendees whose efforts contributed to the success of GA²CI activities at EAACI 2026.

​

Prof Mohamed Abuzakouk
GA2CI President